173 related articles for article (PubMed ID: 7801787)
21. Monoisoamyl meso-2,3-dimercaptosuccinate as a delayed treatment for mercury removal in rats.
Kostial K; Kargacin B; Blanusa M; Piasek M; Jones MM; Singh PK
Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):309-11. PubMed ID: 7843123
[TBL] [Abstract][Full Text] [Related]
22. Determination and metabolism of dithiol chelating agents. XV. The meso-2,3-dimercaptosuccinic acid-cysteine (1:2) mixed disulfide, a major urinary metabolite of DMSA in the human, increases the urinary excretion of lead in the rat.
Maiorino RM; Aposhian MM; Xu ZF; Li Y; Polt RL; Aposhian HV
J Pharmacol Exp Ther; 1993 Dec; 267(3):1221-6. PubMed ID: 8263783
[TBL] [Abstract][Full Text] [Related]
23. Effects of meso-2,3-dimercaptosuccinic acid (DMSA) on methyl mercury-induced teratogenesis in mice.
Sanchez DJ; Gomez M; Llobet JM; Domingo JL
Ecotoxicol Environ Saf; 1993 Aug; 26(1):33-9. PubMed ID: 7691533
[TBL] [Abstract][Full Text] [Related]
24. The influence of chelating agents on the distribution and biotransformation of methylmercuric chloride in rats.
Planas-Bohne F
J Pharmacol Exp Ther; 1981 May; 217(2):500-4. PubMed ID: 6262488
[TBL] [Abstract][Full Text] [Related]
25. Decreasing 203Hg retention by intraperitoneal treatment with monoalkyl esters of meso-2,3-dimercaptosuccinic acid in rats.
Kostial K; Blanusa M; Simonović I; Jones MM; Singh PK
J Appl Toxicol; 1993; 13(5):321-5. PubMed ID: 8258628
[TBL] [Abstract][Full Text] [Related]
26. Toxicokinetics of mercury elimination by succimer in twin toddlers.
Fayez I; Paiva M; Thompson M; Verjee Z; Koren G
Paediatr Drugs; 2005; 7(6):397-400. PubMed ID: 16356027
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the effectiveness of 2,3-dimercaptopropanol (BAL) and meso-2,3-dimercaptosuccinic acid (DMSA) as protective agents against mercuric chloride-induced nephrotoxicity in rats.
de la Torre A; Bellés M; Llobet JM; Mayayo E; Domingo JL
Biol Trace Elem Res; 1998 Jul; 63(1):1-10. PubMed ID: 9764565
[TBL] [Abstract][Full Text] [Related]
28. DMSA administration to patients with alleged mercury poisoning from dental amalgams: a placebo-controlled study.
Sandborgh Englund G; Dahlqvist R; Lindelöf B; Söderman E; Jonzon B; Vesterberg O; Larsson KS
J Dent Res; 1994 Mar; 73(3):620-8. PubMed ID: 8163732
[TBL] [Abstract][Full Text] [Related]
29. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.
Flora SJ; Pande M; Kannan GM; Mehta A
Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL543-51. PubMed ID: 15555419
[TBL] [Abstract][Full Text] [Related]
30. Lipoic acid in combination with a chelator ameliorates lead-induced peroxidative damages in rat kidney.
Sivaprasad R; Nagaraj M; Varalakshmi P
Arch Toxicol; 2002 Aug; 76(8):437-41. PubMed ID: 12185410
[TBL] [Abstract][Full Text] [Related]
31. 2,3-Dimercaptosuccinic acid treatment of heavy metal poisoning in humans.
Fournier L; Thomas G; Garnier R; Buisine A; Houze P; Pradier F; Dally S
Med Toxicol Adverse Drug Exp; 1988; 3(6):499-504. PubMed ID: 2851085
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of chronic occupational lead poisoning with dimercaptosuccinic acid (DMSA)].
Grandjean P; Jacobsen IA; Jørgensen PJ; Lings S; Andersen O
Ugeskr Laeger; 1991 Oct; 153(41):2897-9. PubMed ID: 1659012
[TBL] [Abstract][Full Text] [Related]
33. Beneficial role of monoesters of meso-2,3-dimercaptosuccinic acid in the mobilization of lead and recovery of tissue oxidative injury in rats.
Saxena G; Pathak U; Flora SJ
Toxicology; 2005 Oct; 214(1-2):39-56. PubMed ID: 16019123
[TBL] [Abstract][Full Text] [Related]
34. [Effect of Na-DMS (dimercaptosuccinic acid disodium salt) on the acceleration of lead excretion].
Tachi M; Miyata S; Matsuda Y
Igaku To Seibutsugaku; 1966 Jul; 73(1):35-42. PubMed ID: 4961203
[No Abstract] [Full Text] [Related]
35. DMSA.
Altern Med Rev; 2000 Jun; 5(3):264-7. PubMed ID: 10869106
[No Abstract] [Full Text] [Related]
36. Urine mercury excretion following meso-dimercaptosuccinic acid challenge in fish eaters.
Ruha AM; Curry SC; Gerkin RD; Caldwell KL; Osterloh JD; Wax PM
Arch Pathol Lab Med; 2009 Jan; 133(1):87-92. PubMed ID: 19123743
[TBL] [Abstract][Full Text] [Related]
37. Human studies with the chelating agents, DMPS and DMSA.
Aposhian HV; Maiorino RM; Rivera M; Bruce DC; Dart RC; Hurlbut KM; Levine DJ; Zheng W; Fernando Q; Carter D
J Toxicol Clin Toxicol; 1992; 30(4):505-28. PubMed ID: 1331491
[TBL] [Abstract][Full Text] [Related]
38. EDTA redistribution of lead and cadmium into the soft tissues in a human with a high lead burden - should DMSA always be used to follow EDTA in such cases?
Crinnion WJ
Altern Med Rev; 2011 Jun; 16(2):109-12. PubMed ID: 21649453
[TBL] [Abstract][Full Text] [Related]
39. Determination of 2,3-dimercaptosuccinic acid in mice blood and tissues by HPLC with fluorescence detection.
Ju XH; Shi Y; Liu N; Guo RC; Wang BJ; Cui X
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jun; 877(16-17):1621-6. PubMed ID: 19394283
[TBL] [Abstract][Full Text] [Related]
40. Effect of L-arginine, dimercaptosuccinic acid (DMSA) and the association of L-arginine and DMSA on tissue lead mobilization and blood pressure level in plumbism.
Malvezzi CK; Moreira EG; Vassilieff I; Vassilieff VS; Cordellini S
Braz J Med Biol Res; 2001 Oct; 34(10):1341-6. PubMed ID: 11593311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
